Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor
- PMID: 1359539
- PMCID: PMC50353
- DOI: 10.1073/pnas.89.21.10435
Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor
Abstract
We inoculated rabbits with synthetic phosphopeptides, duplicating a major autophosphorylation site of the c-erbB-2 protooncogene product. The rabbits produced antisera that, after reverse immunoaffinity purification, selectively recognize the erbB-2 protein in its enzymatically active configuration. These anti-phosphopeptide antisera identify a subset of erbB-2-positive human cell lines wherein the protein is constitutively active as a tyrosine kinase. Synthetic phosphopeptides incorporating informative protein phosphorylation sites may prove useful for generating antibodies that indicate the activation state of additional tyrosine kinases and perhaps other proteins phosphorylated on serine and threonine residues.
Similar articles
-
Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites.Oncogene. 1995 Jul 20;11(2):315-23. Oncogene. 1995. PMID: 7624146
-
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.Proc Natl Acad Sci U S A. 1990 Apr;87(7):2569-73. doi: 10.1073/pnas.87.7.2569. Proc Natl Acad Sci U S A. 1990. PMID: 1969636 Free PMC article.
-
Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):95-103. doi: 10.1016/0960-0760(92)90192-l. J Steroid Biochem Mol Biol. 1992. PMID: 1356018 Review.
-
The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.Mol Cell Biol. 1991 Feb;11(2):833-42. doi: 10.1128/mcb.11.2.833-842.1991. Mol Cell Biol. 1991. PMID: 1671296 Free PMC article.
-
Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.Pathol Annu. 1992;27 Pt 1:165-90. Pathol Annu. 1992. PMID: 1346551 Review.
Cited by
-
Extracting functional information from tissues.Mol Diagn. 2001 Mar;6(1):13-5. doi: 10.1007/BF03262099. Mol Diagn. 2001. PMID: 11257207 No abstract available.
-
Activation of ErbB2 during wallerian degeneration of sciatic nerve.J Neurosci. 1997 Nov 1;17(21):8293-9. doi: 10.1523/JNEUROSCI.17-21-08293.1997. J Neurosci. 1997. PMID: 9334404 Free PMC article.
-
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.Am J Pathol. 1996 Feb;148(2):549-58. Am J Pathol. 1996. PMID: 8579117 Free PMC article.
-
Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11526-33. doi: 10.1073/pnas.94.21.11526. Proc Natl Acad Sci U S A. 1997. PMID: 9326643 Free PMC article.
-
Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.Biochem J. 1998 Apr 1;331 ( Pt 1)(Pt 1):113-9. doi: 10.1042/bj3310113. Biochem J. 1998. PMID: 9512468 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous